Blog

Navigating Unwanted ImmunogenicityPart 3 - Challenges & insights in biologic drug developmentOver the past two and a half decades, biologics development has been growing exponentially, matching the pace of small molecules development in 20221. Biologics, or biopharmaceutical products, encompass a wide range of therapeutic products such as vaccines, monoclonal antibodies, gene and cell therapy, and recombinant and fusion therapeutic proteins.Read more

Genoskin at the European Mast Cell and Basophil Research Network meeting in ToulouseAdvancing mast cell research through in vitro evaluation of mast cell responsesWe were thrilled to participate in the prestigious European Mast cell and Basophil Research Network (EMBRN) Conference, which took place in Genoskin’s hometown, Toulouse, France, from May 29-31, 2024. This event brought together prominent academic researchers, clinicians,Read more

Transforming Drug SafetyThe Revolutionary Role of Investigative Toxicology in Drug DevelopmentIn an era where the pace of pharmaceutical innovation is rapidly evolving, the field of toxicology is undergoing a transformative shift. This goes beyond subtle changes; there is a fundamental reimagining of its role from observing drug-induced effects to proactively shaping drug safety measures.The Integration of Investigative Toxicology The traditionalRead more

Genoskin at the World Vaccine CongressAdvancing Vaccine Research with High-Dimensional Immune ProfilingFrom April 1-4, 2024, the global vaccine community gathered for the World Vaccine Congress in Washington, D.C. Taking place at the heart of the nation's capital, the congress was a cornerstone event for vaccine professionals worldwide, offering a platform for sharing groundbreaking research, fostering collaborations, and exploring the latestRead more

The Silent Crisis in Biomedical Research: Beyond MacaquesFinding an alternative to non-human primates to evaluate human therapeutics In a compelling narrative echoed by Le Monde, the biomedical sector faces a silent crisis, highlighting the geopolitical intricacies and ethical quandaries of scientific research. At its core, the dwindling supply of non-human primates (NHPs), particularly macaques, essential for testing medical treatments, hasRead more

Immunogenicity SeriesPart 2 - Wanted Immunogenicity for Vaccine DevelopmentImmunogenicity is a key concept in vaccine development,referring to the ability of a vaccine to stimulate an immune response in the recipient. It is a desirable and critical characteristic because the effectiveness of a vaccine is directly linked to its ability to induce a robust and protective immune response. Vaccine Development: GlobalRead more